TAX2 peptide immunostimulatory properties were also confirmed in a metastatic model that mimics ID8 ovarian carcinoma peritoneal dissemination, in which flow cytometry analysis of ascites fluids indicated a tendency of increased recruitment of CD4+ T cells in TAX2-treated group (Figure 4i,j), while CD45R+ B lineage does not appear to be affected (Figure 4j). This evidence concerns the gene PTPRC and ovarian carcinoma.